T1	Participants 71 98	anemic patients with cancer
T2	Participants 216 255	patients with cancer-associated anemia.
T3	Participants 556 589	Three hundred sixty-five patients
T4	Participants 605 706	One hundred eighty-three patients were assigned to the 40K arm, and 182 were assigned to the 120K arm
